The Global Health Body Sounds Warning Over Acute Shortage of Obesity Jabs

Less than one in 10 individuals eligible to benefit from obesity jabs like Wegovy are able to get them, states the World Health Organization as it issues its inaugural recommendations on the medications.

Considering in excess of 1,000,000,000 individuals worldwide now obese, it is calling for increased and just availability to GLP-1 medication.

Based on forecasts, more than two billion could be living with obesity by 2030 if no action is taken.

"Our new guidance recognises that obesity is a long-term condition that can be managed with holistic and continuous treatment," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and logistical bottlenecks are major barriers to universal availability to the treatments that can aid individuals in losing considerable body mass, notes the body.

Skinny Jab Scarcity

Even under the current most favorable scenario, the manufacturing of such drugs could only cover around 100 million people – fewer than 10% of those who need them, as stated by the WHO.

The guideline calls on governments and firms to expand availability, through approaches like voluntary licensing.

The intellectual property rights on the active ingredient – the core component of the drug Wegovy – is due to expire in a number of nations in 2026.

The Way Weight-Loss Drugs Operate

These medications mimick a biological compound to slow digestion, curb appetite and boost the sense of being full so individuals eat less.

Patients commonly begin shedding pounds after several weeks of starting on the regular doses.

Studies indicates users may put most of the weight back on after a year of halting the drug, because their normal hunger return.

To be above a healthy weight raises your risk for developing medical conditions, like type 2 diabetes, heart disease, stroke, and certain cancers.

Excess weight affects individuals in every country and was responsible for 3.7 million fatalities worldwide in 2024, according to the health agency.